InvestorsHub Logo
Followers 46
Posts 3422
Boards Moderated 0
Alias Born 10/15/2013

Re: None

Wednesday, 06/12/2019 1:18:36 PM

Wednesday, June 12, 2019 1:18:36 PM

Post# of 427
https://promisneurosciences.com/wp-content/uploads/2019/06/The-Future-of-RD-in-Alzheimers-Disease-ProMIS-Neurosciences.pdf

The Future of R&D
in Alzheimer’s
Disease
New investigational drugs with high selectivity for amyloid-ß oligomers and the use of pharmacodynamic biomarkers in Phase 1 trials to enable early go/no-go decisions are changing the R&D landscape
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMN News